Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novartis H1N1 Vaccine in Asthma Patients
NCT00978120Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2009
- Primary completion
- Sep 2010
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Influenza A (H1N1) vaccine in H1N1 influenza (H1N1), sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2009; status: completed.
02
Drugs
Influenza A (H1N1) vaccine
03
Conditions
H1N1 influenza (H1N1)
Beyond the preview
Go deeper on NCT00978120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00978120.